Japan to mull use of hormone to halt metastases of lung cancer cells

Kenji Kangawa, head of Japan's National Cerebral and Cardiovascular Center, announces at a press conference in Osaka, western Japan, on Feb. 24, 2015, the launch of clinical studies involving hormone administration during lung cancer surgeries in a bid to prevent metastases of carcinogenic cells, billed as the world's first attempt of the kind. (Kyodo) ==Kyodo